Johnson & Johnson to acquire V-Wave Ltd. in $1.1bn deal to enhance heart failure treatment
Johnson & Johnson (NYSE: JNJ) has made headlines with its decision to acquire V-Wave Ltd., a private company renowned for its cutting-edge treatments for heart ... Read More
Bayer announces start of Phase 2 GenePHIT trial for AB-1002
Bayer AG and its subsidiary Asklepios BioPharmaceutical, Inc. (AskBio), have achieved a significant milestone in the fight against congestive heart failure (CHF) with the randomization ... Read More
Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets
Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States Food and Drug Administration (FDA) for its ... Read More
WhiteSwell’s eLym System shows promise in acute decompensated heart failure treatment
WhiteSwell, a frontrunner in the treatment of acute decompensated heart failure (ADHF), has shared optimistic initial results from its continuing DELTA-HF trial centered around the ... Read More
American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint
American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID trial of INJECTAFER (ferric carboxymaltose injection) for ... Read More
China’s NMPA expands AstraZeneca’s Forxiga use as heart failure treatment
China's National Medical Products Administration (NMPA) has approved AstraZeneca's Forxiga (dapagliflozin) for diminishing the risk of cardiovascular fatalities and hospitalizations in adults diagnosed with symptomatic ... Read More
Lupin Digital Health unveils Lyfe Digital Heart Failure Clinic
Indian cardiac digital therapeutics entity, Lupin Digital Health (LDH), marked another achievement with the unveiling of its Lyfe Digital Heart Failure Clinic. Designed to cater ... Read More
BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard ... Read More
Viz.ai, Bristol Myers Squibb sign deal for AI algorithm and Viz HCM software
Viz.ai, an artificial intelligence (AI) powered health technology company, has signed a multi-year agreement with Bristol Myers Squibb (BMY) to provide the latter with an ... Read More
Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India
Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart failure in India under the brand name ... Read More